Talphera (TLPH) Interest Coverage Ratio (2010 - 2026)

Talphera (TLPH) posted quarterly Interest Coverage Ratio of 33.46 for Q1 2026, down 70135.82% quarter-over-quarter from 0.05 in Q4 2025.

Talphera (TLPH) Interest Coverage Ratio (2010 - 2026) Analysis & Trends

Talphera's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 33.46 for Q1 2026.

In Q1 2026, Interest Coverage Ratio changed N/A year-over-year to 33.46; the TTM figure through Mar 2026 stood at 123.02 (changed N/A YoY), while the FY2025 annual figure was 0.19, down 25.59% from the prior year.
Interest Coverage Ratio for Q1 2026 stood at 33.46, down from 0.05 in the prior quarter.
The five-year high for Interest Coverage Ratio was 125.97 in Q4 2023, with the low at 937.25 in Q3 2024.
The 5-year median for Interest Coverage Ratio is 18.81 (2022), against an average of 133.91.
The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio soared 468.11% in 2023, then plunged 2732.43% in 2024.
Talphera's Interest Coverage Ratio stood at 34.22 in 2022, then jumped by 468.11% to 125.97 in 2023, then slumped by 111.89% to 14.98 in 2024, then jumped by 99.68% to 0.05 in 2025, then sank by 70135.82% to 33.46 in 2026.
Business Quant data shows TLPH's Interest Coverage Ratio at 33.46 in Q1 2026, 0.05 in Q4 2025, and 15.14 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	-
3	Zoetis	31.79 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.69 Bn	22.89 Bn	5.10 Bn	-3.15
5	United Therapeutics	22.25 Bn	19.58 Bn	683.80 Mn	114.07
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.05
7	Neurocrine Biosciences	15.58 Bn	15.19 Bn	935.80 Mn	52.24
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	4.20
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	Talphera	90.35 Mn	90.35 Mn	-	-

Download Data